While there are no overt clinical symptoms, such as loss of mobility or paralysis, as observed in other MS models (e.g. EAE), cuprizone-demyelinated mice exhibit more subtle motor and cognitive deficits. These deficits may be detectable in open-field and Y-maze cognition & memory assessments, as well as rotarod motor assessments (Franco-Pons, 2007).